Cargando…
Clinical impact of different exosomes’ protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
INTRODUCTION: Pancreatic ductal adenocarcinoma is associated to dismal prognosis despite the use of palliative chemotherapy, partly due to the lack of knowledge of biological processes underlying disease progression. Exosomes have been identified as biomarkers sources in different cancer types. Aim...
Autores principales: | Giampieri, Riccardo, Piva, Francesco, Occhipinti, Giulia, Bittoni, Alessandro, Righetti, Alessandra, Pagliaretta, Silvia, Murrone, Alberto, Bianchi, Francesca, Amantini, Consuelo, Giulietti, Matteo, Ricci, Giulia, Principato, Giovanni, Santoni, Giorgio, Berardi, Rossana, Cascinu, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497273/ https://www.ncbi.nlm.nih.gov/pubmed/31048929 http://dx.doi.org/10.1371/journal.pone.0215990 |
Ejemplares similares
-
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival
por: Amantini, Consuelo, et al.
Publicado: (2019) -
CXCL12 and Its Isoforms: Different Roles in Pancreatic Cancer?
por: Righetti, Alessandra, et al.
Publicado: (2019) -
Computational analysis of the mutations in BAP1, PBRM1 and SETD2 genes reveals the impaired molecular processes in renal cell carcinoma
por: Piva, Francesco, et al.
Publicado: (2015) -
Emerging Biomarkers in Bladder Cancer Identified by Network Analysis of Transcriptomic Data
por: Giulietti, Matteo, et al.
Publicado: (2018) -
Progress of Molecular Targeted Therapies for Advanced Renal Cell Carcinoma
por: Conti, Alessandro, et al.
Publicado: (2013)